Abstract. Aberrant axonal reorganization and altered distribution of neurotransmitter receptor subtypes have been proposed as major pathogenic mechanisms for hippocampal hyperexcitability in chronic temporal lobe epilepsies (TLE). Recent data point to excitatory class I metabotropic glutamate receptors (mGluR1 and mGluR5) as interesting candidates. Here, we have analyzed the hippocampal distribution and mRNA expression of mGluR1 and mGluR5 in two rat models of limbic seizures, i.e. electrical kindling and intraperitoneal kainate injections, as well as in human TLE. Quantitative RT-PCR analysis detected a significant increase of hippocampal mGluR1 gene transcript levels in kainate treated and kindled rats. In addition, microdissected hippocampal tissue samples localized this increase to the dentate gyrus. Using immunohistochemistry with mGluR1␣ subtype specific antibodies, increased labeling was observed within the dentate gyrus molecular layer (DG-ML). A similar pattern of increased mGluR1␣ neuropil staining was found within the DG-ML of epilepsy patients (n ϭ 42) compared with peritumoral hippocampus specimens obtained from nonepileptic patients (biopsy controls, n ϭ 3). This increase was detected in TLE patients with segmental hippocampal cell loss, as well as in TLE patients with focal lesions but no histopathological alterations of the hippocampus. In contrast, mGluR5 immunoreactivity and mRNA expression were not significantly altered in the DG-ML. Our data demonstrate a striking regional induction of mGluR1␣ in the hippocampal dentate gyrus of experimental animals with limbic seizures as well as in human patients with chronic, intractable TLE. This increase corresponds to functional alterations of class I mGluRs observed in seizure models and may significantly contribute to hippocampal hyperexcitability in focal human epilepsies.
INTRODUCTION
The molecular mechanisms underlying increased hippocampal excitability in human temporal lobe epilepsy (TLE) and in rat models of limbic seizures remain largely unknown (1) . A popular hypothesis postulates that an imbalance between excitatory and inhibitory neurotransmission pathways in the epileptic hippocampus may contribute substantially to a decreased seizure threshold. Alterations in the expression and distribution of neurotransmitter systems, such as the inhibitory GABA A receptor, have been described in epileptic rats and human temporal lobe epilepsy (2) (3) (4) . L-glutamate represents the major excitatory neurotransmitter in the hippocampus. It acts via ionotropic and metabotropic glutamate receptors. These receptor systems have emerged as interesting target molecules associated with epileptogenesis and antiepileptic pharmacological treatment. In particular, metabotropic glutamate receptors (mGluR) represent an attractive candidate for a receptor family involved in TLE, which comprises at least eight different subtypes (5, 6) . Activation of class I mGluRs (i.e. mGluR1 and mGluR5) leads to an excitatory membrane depolarization followed by release of Ca 2ϩ from intracellular stores, which appears to be mediated by inositol phosphate hydrolysis. Class II (mGluR2 and mGluR3) and class III (mGluR4, mGluR6-8) mGluRs are considered inhibitory receptors. They operate through a G-protein-mediated inhibition of adenylate cyclase. Immunohistochemical studies and in situ hybridization analyses revealed distinct pre-or postsynaptic localization of mGluR isoforms in rat (7, 8) and human hippocampus (9) . Recent molecular, pharmacological, and physiological data point to a role for specific mGluR subtypes during the propagation of epileptiform activity in the mammalian brain (10) (11) (12) (13) . In particular, agonists of excitatory class I mGluRs exert significant convulsant properties, whereas class I antagonists can prevent seizure-induced brain damage in different animal models. Furthermore, animal models of limbic epilepsy, i.e. kainate induced seizures or electrical kindling, revealed enhanced activity of class I mGluRs associated with increased phosphoinositide hydrolysis (14, 15) . These properties raise the question whether differential regulation of distinct mGluR subtypes contributes to the pathogenesis of human TLE and suggest mGluRs as potential targets for the pharmacological treatment of chronic therapy-refractory epilepsies.
A major obstacle for the analysis of human TLE specimens is the lack of normal, age-matched controls. Several approaches can be taken to address this problem. The majority of patients with intractable, chronic mesial TLE exhibit Ammon's horn sclerosis (AHS) characterized by segmental neuronal cell loss, reactive gliosis, and aberrant axonal reorganization within the hippocampal formation (16) . A second group of TLE patients present with focal lesions in the temporal lobe, i.e. glio-neuronal neoplasms or malformations. Presurgical evaluation points to an involvement of the hippocampal formation during epileptogenesis in some of these lesional patients (17) , although histopathological analysis usually fails to demonstrate significant changes (18, 19) . In addition to a comparative analysis of tissue samples from TLE patients with different neuropathological alterations, i.e. AHS versus focal lesions, biopsy samples obtained from tumor patients without chronic epileptic seizures may serve as control tissue and provide important information. Autopsy controls represent a third option. However, variable postmortem intervals and differences in tissue processing may affect its value for immunohistochemical or molecular analysis. In particular, decreased protein and/or mRNA levels may result from postmortem degradation. The investigation of animal models for TLE provides yet another possibility to evaluate and confirm anatomical, physiological, and/or molecular changes detected in human epilepsy specimens. Intraperitoneal injection of the glutamate analog kainate induces chronic limbic seizures and a hippocampal neuropathology resembling that of AHS, i.e. segmental neuronal cell loss, gliosis, and aberrant axonal reorganization in rats (20) . On the other hand, moderate kindling is not accompanied by severe neuropathological alterations within the hippocampus and may thus represent a useful model for lesional TLE specimens (21) . Both models may thus help to clarify pathogenetic changes detected in human TLE samples.
In the present study we analyzed the expression and localization of the excitatory class I metabotropic glutamate receptors mGluR1 and mGluR5 in the hippocampus of two animal models of limbic seizures and compared their patterns with hippocampal distribution in human patients with chronic TLE.
MATERIAL AND METHODS

Kainate Model of Limbic Seizures
Ten young adult male Sprague-Dawley rats (26-33 d; 60-80 g) were injected twice with kainic acid (KA), 12.5 mg/kg intraperitoneally (i.p.), on two consecutive days. Five animals received saline vehicle only. All animals were carefully monitored for 4-6 h after the injection. KA-exposed rats developed epileptic seizures that occurred 15-20 min after drug administration. The seizures were characterized by recurrent ''wet dog shakes'' and rearing, followed by bilateral forelimb clonus and occasional falling and jumping. Eight animals showed bouts of generalized tonic-clonic seizures after the second injection, which lasted for at least 1 h. The animals were housed under standard laboratory conditions for survival periods of 30 d. Prior to decapitation, the animals were monitored for 12 h for the presence of spontaneous seizures. Only animals without such seizure activity were anaesthetized with chloroform and the brains were immediately removed and processed as follows: the right hippocampus was rapidly frozen in liquid nitrogen and stored at Ϫ80ЊC; the left hippocampus was immersion fixed in 4% neutrally buffered paraformaldehyde overnight and sectioned into 60-m-thick slices using a vibratome (Campden, GB). All sections were collected in miniwell plates filled with cryoprotection solution containing 33% ethylene glycol and 25% glycerol in phosphate buffer (0.1 M, pH 7.4) and stored at Ϫ20ЊC until further use. For neuropathological evaluation, slices from each hippocampus were embedded in paraffin, cut into 4-m-thick sections, and stained with hematoxylin-eosinluxol-fast-blue (H&ELFB) Nissl's reagent. Five untreated adult Sprague-Dawley rats (30 and 60 d of age) were used as additional controls.
Kindling Model of Limbic Seizures
Adult male Sprague-Dawley rats (59 Ϯ 3 d, body weight 310 Ϯ 33 g, n ϭ 12) were anesthetized using intramuscular injection of Ketanest (Ketavet 100 mg/ml) and Xylazine (Rompun 2%) at an initial dose of 100 mg/kg and 5 mg/kg, respectively. During the stereotaxic procedure, an additional injection was given i.p. (50% of initial dose). Stainless steel electrodes (MS 303-3, Plastics One, Bilaney Consultans GmbH, Dusseldorf, Germany) were implanted into the left amygdala. The stereotaxic coordinates were as follows: posterior 2.5 mm, lateral 3.6 mm, ventral (below dura) 7.8 mm, incisor bar 3.3 mm (22) . Following a recovery period of 2 wk, electrical stimulation was carried out in six animals using a uniform stimulation intensity of 450 A for 1 s (Isostim A320; WPI, FRG). Seizures were classified according to Racine (23) . The kindling protocol was continued for 60 d following onset of stage 5 seizures, which developed after 13 Ϯ 2 d. Six control animals were implanted but received no electrical stimulations (sham controls). Three untreated adult Sprague-Dawley rats (105-127 d of age) were used as additional controls. All animals were housed under standard laboratory conditions. Twenty-four to 48 h after the last kindling stimulation, the animals were anesthetized with chloroform, killed by decapitation, and the brains were immediately removed. The tissue was collected in chilled Ringer's solution equilibrated with carbogen (95% CO 2 , 5% O 2 ), and processed as follows: whole brain specimens were horizontally blocked onto a vibratome and consecutively cut into 400-m-thick sections. From the left hemisphere, the hippocampus was dissected, immediately snap frozen in liquid nitrogen, and stored at Ϫ80ЊC. From the right hippocampus, the dentate gyrus, CA3, and CA1 regions were microdissected under a stereomicroscope (Leitz, FRG) and deep frozen. We excluded the transition area between CA1 and CA3, i.e. CA2 (24) , because this field cannot be unequivocally delineated under the stereomicroscope. For neuropathological evaluation, samples of the hippocampus and amygdala were embedded in paraffin, cut into 4-m-thick sections, and stained with H&ELFB or Nissl's reagent. The position of electrodes was histologically verified on H&E stained sections.
A total of 42 biopsy specimens of the hippocampus were examined. The surgical tissue has been obtained from patients with chronic pharmaco-resistant TLE who were enrolled in the Epilepsy Surgery Program at the University of Bonn Medical Center. The epileptogenic focus was localized to the temporal lobe in all patients by noninvasive or invasive diagnostic procedures, as described elsewhere (17) . In all patients, surgical removal of the hippocampus was necessary to achieve seizure control. At the time of surgery, all patients were under a full antiepileptic drug regimen. Informed and written consent was obtained from all patients for additional studies. All procedures were conducted in accordance with the Declaration of Helsinki and approved by the ethics committee of the University of Bonn Medical Center. The surgical specimens were collected immediately after resection in chilled Ringer solution equilibrated with carbogen. Tissue preparation and processing were as follows: (i) A 2-to 3-mm-thick tissue block was prepared for free floating immunohistochemical analysis. For this purpose, the tissue was immersion fixed overnight in 4% paraformaldehyde (0.1 M phosphate buffer, pH 7.4) prior to vibratome sectioning into 60-m-thick slices. The sections were stored in a cryoprotection solution containing 33% ethylene glycol and 25% glycerol in 0.1 M PB until further use. (ii) An additional block was immersion fixed in 4% formalin overnight and processed in liquid paraffin.
Three hippocampal specimens were obtained during tumor surgery and were processed similar to the surgical specimens mentioned above (age: 38.7 Ϯ 2.4 yr). These patients had no history of epileptic seizures but suffered from a glioblastoma multiforme (WHO grade IV) or anaplastic oligoastrocytoma (WHO grade III) located adjacent to the hippocampal formation. Histopathological examination excluded tumor cell invasion into the hippocampus proper or other neuropathological alterations within the hippocampal formation. All hippocampal specimens analyzed in this study were obtained from the middle portion of the main hippocampal body.
Clinical Parameters of TLE Patients
Clinical data for TLE patients included in this study were retrieved from the files of the Department of Epileptology at the University of Bonn Medical Center. All patients suffered from complex partial seizures (CPS), 16 from additional simple partial seizures, whereas 33 of these patients also had secondary generalized seizures. The mean age of the patients was 32.6 Ϯ 8.7 yr; they experienced 13.3 Ϯ 11.3 CPS/month, and the age at onset of epilepsy was 11.3 Ϯ 7.8 yr. The comparison of TLE patients presenting with AHS or focal lesions within the temporal lobe revealed no significant differences with respect to the age of the patient at the time of surgery (AHS: 33.1 Ϯ 6 yr vs lesion: 30.4 Ϯ 12.8 yr) and the age at seizure onset (AHS: 9.8 Ϯ 5.5 yr vs lesion: 14.4 Ϯ 11.8 yr, p Ͻ 0.5). Although there was a slight difference in duration of the disease (AHS: 23.5 Ϯ 8 yr vs lesion: 16.8 Ϯ 10.5 yr; p Ͻ 0.1), it did not reach statistical significance. The mean age of TLE patients was not different from that of tumor patients without a history of epileptic seizures.
Neuropathological Evaluation of TLE Specimens
All TLE specimens were independently examined by two neuropathologists and classified with respect to the presence of AHS (n ϭ 32) or focal lesions (n ϭ 10). AHS was characterized by extensive neuronal cell loss and concomitant astrogliosis in the CA1, CA3, and CA4 subfields with relative sparing of CA2 and the granule cell layer of the dentate gyrus (1). In most non-AHS patients, focal lesions were found in the subcortical white matter or temporo-mesial cortex. None of these lesions extended into the hippocampus proper. Histopathological diagnoses included glio-neuronal hamartias or hamartomas (n ϭ 2), ganglioglioma WHO grade I (n ϭ 2), astrocytoma WHO grade I or II (n ϭ 3), oligoastrocytoma WHO grade II, and abundant neurons in the white matter (n ϭ 2) (25, 26) . Two of these patients presented with dual pathology of AHS and a focal lesion within the temporal lobe, i.e. glio-neuronal hamartias. In two additional patients, neither hippocampal nor extrahippocampal pathology could be demonstrated by neuroradiological and histopathological examination.
Neuronal cell densities within the hippocampal pyramidal cell layers as well as within the granule cell layer of the DG were quantitatively assessed using semiautomated imaging analysis of NeuN immunoreactivity according to Lie et al (27) . All specimens were scanned at a magnification of ϫ400. Each labeled nucleus was tagged on the computer screen. The number of objects and the respective regions of interest (ROI), defined by the constant area viewed on the computer screen, were calculated using the IP Lab imaging analysis software. The results from five adjacent ROIs per hippocampal subfield were recorded, averaged, and expressed as mean cell number/mm 2 (neuronal cell density). Since the CA2 segment of rat hippocampus was not clearly identifiable, cell counts of this field were not included. All data were analyzed statistically using the statistical software package SPSS version 6.1.2. (SPSS Inc., Munich, Germany). Values were expressed as mean Ϯ standard error of the mean (SEM). Significant group effects were confirmed by analysis of variance (ANOVA) and post-hoc Duncan's test for multiple group comparison with a significance level at p Ͻ 0.05.
Immunohistochemistry
Metabotropic glutamate receptor localization was examined using polyclonal antibodies raised against the mGluR1␣ (1: 1,000; Chemicon, Hofheim, Germany) and the mGluR5 (J139, Dr. Emson, Cambridge, UK) subtype. The mGluR5 antibody was raised against the amino terminus of human mGluR5 using a 126 amino acid fusion protein (position 170 through 296). For immunohistochemical staining 60-m-thick vibratome sections were incubated free floating using standard protocols (9) . For the analysis of receptor distribution, hippocampal specimens from human patients, controls and experimental animals were studied by optical densitometry. All sections were examined at a final magnification of ϫ400 with a Vanox microscope (Olympus, Japan) and the images were scanned at equal light conditions with a CCD video camera (Sony, Japan). From each hippocampal subfield, 5 ROI were selected on the monitor and the optical density OD ROI was automatically determined using 
Quantitative Analysis of Class I mGluR Gene Transcripts
A competitive RT-PCR assay was employed for the quantitative assessment of class I mGluR gene transcript levels in rat hippocampal tissue as described previously (28) . Briefly, total RNA was reverse transcribed (Superscript, Gibco, Karlsruhe, Germany) and cDNA product was generated by PCR. The primer sequences used for the amplification of mGluR and reference gene transcripts were designed to amplify a region with minimal homology between individual mGluRs (mGluR1: forward 5Ј GATGAGAAGGATGGGCTGAA, reverse 5Ј CAAA-TACTTCCTGAGGGTGG, database accession # M61099; mGluR5: forward 5Ј GGCCATTCAAGTCCAGAACT, reverse 5Ј GTGTGCACAGCTGAGA-CATA, database accession # D10891). In order to standardize the reaction for the amount of total RNA used for the reverse transcription (RT), the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was simultaneously analyzed. Internal competitor templates for the in vitro transcription were generated in a PCR reaction through addition of a T7 promotor sequence 5Ј of the forward primer binding site and deletion of approximately 10% of bases at the opposite end adjacent to the reverse primer binding site. The introduced deletion was confirmed by DNA sequencing of the PCR product (ABI 373A; Perkin Elmer, Weiterstadt, Germany). The mutagenized PCR product was transcribed into RNA using T7 RNA polymerase as described by the manufacturer (Stratagene, Heidelberg, Germany). Following photometric determination, 0.5 g of total RNA from each hippocampus were reverse transcribed into cDNA together with 25 ϫ 10 Ϫ6 , 5 ϫ 10 Ϫ6 , and 10 Ϫ6 g of the mutagenized mGluR competitor RNA and 10 Ϫ3 , 2 ϫ 10 Ϫ4 , 4 ϫ 10 Ϫ5 g of the exogenous GAPDH competitor RNA, respectively. The cDNAs were PCR amplified with fluorescence labeled reverse primers (Perkin Elmer). Cycle numbers were optimized to represent a linear range of the PCR amplification. Amplicons were separated on a 6% denaturing acrylamide gel and analyzed by laser densitometry on a semiautomated DNA sequencer (ABI 373A; Fig. 1A ) using the Genescan software, version 1.2.1, Perkin Elmer (Fig. 1B) . The level of mGluR1 and mGluR5 gene transcripts was calculated as follows: The ratio (mGluR sample / mGluR competitor ) was determined for each concentration of competitor transcript added to the RT reaction; the titration point (TP1 mGluR ϭ mGluR sample /mGluR competitor ϭ 1) indicates the amount of mGluR transcript present in the sample. The same calculation Two patients with dual pathology, i.e. focal lesion and AHS, were excluded. was carried out for GAPDH (TP1 GAPDH ). This value was used as reference for the unknown amount of total mRNA added to the RT-reaction. To allow a comparison between individual animals or groups of animals, the mean value of TP1
GAPDH was calculated and the difference between the mean and each separate TP1 GAPDH served as reference factor for the normalization of mGluR levels. Inter-group comparisons of mGluR expression levels were carried out using statistical analysis of variance (ANOVA) and post-hoc Duncan's test for multiple group comparison with a level of significance set at p Ͻ 0.05.
RESULTS
Neuropathological Evaluation
Immunohistochemical evaluation of hippocampal neuron cell densities revealed distinct patterns of alterations (Table 1) . Epileptic rats subjected to amygdala kindling showed no significant differences compared with agematched controls or sham operated animals. In contrast, kainate treatment induced significant neuronal cell loss within the hilus, CA3 and CA1 segments. In human surgical TLE specimens of the hippocampus, significant neuronal cell loss in segments CA4, CA3, and CA1 (p Ͻ 0.05) was only demonstrated in AHS patients. Hippocampal neuron cell densities obtained from TLE-patients with focal lesions showed no significant changes in any of the hippocampal segments compared with normal controls.
Semi-quantitative RT-PCR Analysis of Class I mGluR Gene Transcript Levels in the Hippocampus of Kainate Treated or Kindled Rats
Reverse transcriptase-PCR reactions with total RNA extracted from rat hippocampus elicited significant levels of mGluR1 and mGluR5 transcript. Compared with sham injected and age-matched control animals, kainate treated and kindled rats revealed a 2-to 3-fold up-regulation of mGluR1 expression (Fig. 1C) . In contrast, mGluR5 expression showed no differences between control and experimental animals (Fig. 1D) . Furthermore, microdissection of hippocampal slices from kindled, sham implanted, and age-matched control animals demonstrated a significant up-regulation of mGluR1 transcript levels within the dentate gyrus of kindled rats ( Fig. 2A) . No differences were detected for mGluR1 expression in CA1 and CA3 for kindled animals compared with controls or sham implanted rats. Compared with mGluR1, transcript levels of mGluR5 were higher and distributed more homogeneously in all three fields. No differences were detected for mGluR5 expression in DG and CA1 in kindled compared with control and sham implanted animals. Decreased levels of mGluR5 were, however, observed in the CA3 segment of kindled animals (Fig. 2B ).
Hippocampal Distribution of Class I mGluR Immunoreactivity in Animal Models of Limbic Seizures
In the hippocampus of control and sham injected or sham implanted rats, antibodies to mGluR1␣ yielded a strong reaction of interneurons within the stratum oriens of CA1 and CA3. In the hilus, few neurons and their dendritic profiles were also labeled. In addition, neuropil labeling of the CA1 region and to a lesser degree in the dentate gyrus molecular layer was visible in the tissue samples (Fig. 3A, C) . In both groups of experimental animals, i.e. kindling and kainate, a distinct increase of mGluR1␣ immunoreactivity was apparent within the DG-ML (Figs. 3B, D; 5) . All other segments of the hippocampal formation revealed no specific alterations of the mGluR1␣ immunoreactive cellular or regional distribution patterns. The staining pattern of mGluR5 showed intense staining of hippocampal neurons and neuropil (29) . Densitometry of mGluR5 immunoreactivity in hippocampal subfields revealed no significant alterations in both experimental animal models. Hippocampal slices were microdissected and RT-PCR expression analysis was carried out separately for each anatomical region. Significant differences were only detected for mGluR1 in the dentate gyrus (DG) compared with age-matched controls and sham implanted rats. (B) The variability of mGluR5 expression was larger in all hippocampal subfields. In CA3, however, the reduction of mGluR5 mRNA levels reached statistical significance.
Hippocampal Distribution of Class I mGluR Immunoreactivity in TLE Patients
In the hippocampus of biopsy controls, specific immunoreactivity for mGluR1␣ was observed in dendritic profiles of the hilus and the stratum oriens (Fig. 4A) . The latter were likely to derive from interneurons. Cell bodies of principal neurons, however, were never found to be immunoreactive for mGluR1␣. A moderate extent of staining was also visible within the neuropil of the DG-ML, whereas prominent neuropil labeling could be demonstrated in the stratum pyramidale, stratum radiatum, and stratum moleculare-lacunosum of the CA1 segment, as well as the adjacent subiculum. The neuropil of the CA2 and CA3 fields showed only discrete immunoreactivity. Metabotropic glutamate receptor 1␣ protein exhibited a significantly altered regional distribution in human TLE specimens. All TLE patients analyzed, including those with AHS or focal lesions, exhibited dense immunoreactivity of the entire DG-ML (Figs. 4B, D, E; 5) . Hilar dendritic profiles, including those with prominent periodic nodulations, were also mGluR1␣ immunoreactive. Immunoreactivity for mGluR5 showed a dense neuropil labeling within all hippocampal subfields as described elsewhere (9) . Tissue sections obtained from TLE-patients with focal lesions did not demonstrate altered mGluR5 immunoreactivity compared with biopsy controls (Fig. 5) . In AHS patients, a slight decrease of mGluR5 immunoreactivity was observed in DG-ML, most likely resulting from granule cell loss.
DISCUSSION
The present study demonstrates a significant up-regulation of the excitatory mGluR1␣ splice variant in the dentate gyrus of both animal models with limbic seizures and human TLE patients. This increase appears to occur independent from the underlying histopathological alteration, i.e. hippocampi with or without segmental neuronal cell loss. With respect to the dentate gyrus as a major gatekeeper for hippocampal excitability, induction of excitatory mGluR1␣ may represent an important pathomechanism contributing to focal epileptogenesis and/or propagation of seizure activity.
The up-regulation of mGluR1 mRNA and immunoreactivity in the dentate gyrus support recently reported experiments that demonstrated increased mGluR1 receptor mRNA expression in kindled rat hippocampus (14) increased hippocampal inositol phospholipid hydrolysis in the rat kainic acid model (30) and after stimulation with class I mGluR agonists (15) . mGluR1␣ labeling was also observed in the neuropil of CA1, which has not been described in earlier studies (7, 8, 31) . Whether this difference in immunohistochemical reaction patterns has to be attributed to the use of different antibodies, fixation protocols, or animal strains remains to be clarified. In our study, specific up-regulation of mGluR1 mRNA transcript levels and immunoreactivity was observed only in the dentate gyrus molecular layer. The analysis of class I mGluR5 showed no corresponding alterations. We are confident, therefore, that these changes in the distribution of mGluR1 mRNA transcript and immunoreactivity represent a phenomenon associated with hippocampal seizure activity in chronic seizure models and patients with temporal lobe epilepsy.
Experimentally induced chronic seizures using kainic acid or temporal lobe kindling in rats result in dramatic pathophysiological alterations which predominantly affect the dentate gyrus (20) . The dentate gyrus receives major cortical and hypothalamic projections as well as hippocampal commissural and association afferents and constitutes a gatekeeping relay for excitatory input to the hippocampal formation (32, 33) . The induction of excitatory neurotransmitter receptors, such as mGluR1␣, with a concomitant increase of intracellular calcium influx and calcium concentrations, may well contribute to the postulated imbalance between dentate gyrus excitation and inhibition as well as an altered efficacy of synaptic connections in temporal lobe epilepsy. Another interesting property of mGluRs is their activity dependent transmission of glutamatergic signals (34) . Glutamate is rapidly cleared from the synaptic cleft. Increased glutamate release following high frequency activation results in delayed clearance with sustained activation of mGluRs at the periphery of the synapse (34) . This notion is supported by anatomical data showing that class I mGluRs cluster at the periphery of the synapse (7). Indeed, activation of mGluR1 during high frequency stimulation has been associated with the induction of LTP in the CA1 region, since transgenic mice lacking the mGluR1 gene show reduced LTP at the Schaffer collateral-CA1 synapse (35) . It has previously been reported that brief seizure episodes are able to induce long-lasting changes in synaptic transmission reminiscent of LTP (36) . Thus, up-regulation of mGluR1 may provide an attractive mechanism of activity dependent potentiation of excitatory synaptic transmission, rather than contributing to a static imbalance between inhibitory and excitatory signal transduction. Another activity dependent regulation has recently been proposed for GABA A receptors on dentate granule cells that show an enhanced zinc ion sensitivity in chronically epileptic tissue due to a GABA A receptor subunit switch (2). The altered pharmacological property of the new receptor complex may result in a block of GABA A receptors following Zn 2ϩ release from recurrent mossy fiber terminals after high frequency activation, possibly leading to a collapse of inhibition (2) . These and other activity dependent mechanisms extend previous hypotheses of an imbalance between excitation and inhibition and may help to explain the random occurrence of epileptic seizures.
The intriguing finding of increased mGluR1␣ immunoreactivity in experimental animal models has been corroborated in both major groups of TLE patients, i.e. AHS and focal lesions. Similar patterns of up-regulated ionotropic neurotransmitter receptors were reported in immunohistochemical and in situ hybridization studies of hippocampal NMDA and AMPA receptor subunits in human TLE patients, i.e. AMPA GluR1 and NMDA R2 (37, 38), as well as for GABA and glutamate transporter molecules (39) . In TLE patients with hippocampal sclerosis, marked structural changes appear to contribute to the enhanced seizure susceptibility (1, (40) (41) (42) (43) . In particular, selective neuronal vulnerability (44) , altered dendritic ramification (45, 46) , and aberrant synaptic reorganization (43) have been proposed as major pathophysiological conditions. Altered expression patterns of neurotransmitter receptor systems may represent yet another mechanism contributing to hippocampal hyperexcitability (37) . This notion is supported by the finding of increased neurotransmitter receptor expression in TLE patients with focal lesions who usually do not show severe structural abnormalities (1). Distinct molecular changes, i.e. in the composition and expression of excitatory or inhibitory neurotransmitter systems may account for hippocampal hyperexcitability in many of these patients. This hypothesis is corroborated by animal models such as kindling epilepsy, in which hippocampal epileptogenesis is not always related to structural abnormalities of the hippocampal formation. The regional increase of mGluR1␣ in TLE patients with focal lesions emerges from this study as a novel molecular alteration of potential pathogenic importance. The use of different experimental animal models of limbic seizures with or without structural hippocampal abnormalities can be helpful in characterizing the significance of this finding. Both animal models employed in this study revealed a similar up-regulation of mGluR1␣ in the DG-ML as shown by immunohistochemical as well as molecular techniques. In particular, microdissection of hippocampal subregions confirmed the region-specific increase of mGluR1␣ transcript in the dentate gyrus. The consistent detection of mGluR1␣ up-regulation in the DG-ML from TLE patients with or without AHS, as well as in different experimental animal models, appears to suggest a mechanism common to hippocampal epileptogenesis in different forms of TLE.
Metabotropic glutamate receptors may be particularly interesting targets for drug development, as antagonists at these receptors would preferentially be effective during pathological high frequency activity. Indeed, various pharmacological experiments in vitro and in vivo have indicated that mGluRs are candidate molecules for the treatment of neurological disorders, including epilepsy or ischemia (5, 6) . In principle, activation of class I mGluRs exerts proconvulsive effects whereas class II or III mGluRs have been associated with anticonvulsive activity. Class I agonists aggravate seizures and neuronal damage (47, 48) , whereas application of class II mGluR agonists has been linked to neuroprotective and antiepileptic mechanisms (49, 50) . Similarly, (S)-4C3HPG, an agonist of class II and an antagonist of class I mGluRs can block convulsions in seizure-prone DBA/2 mice or rats (13) .
In conclusion, the findings of this study indicate that mGluR1␣ is significantly up-regulated in the dentate gyrus of epileptic human and rat hippocampus. This upregulation may significantly contribute to hippocampal epileptogenicity and points to mGluRs as potential targets in the search for novel antiepileptic drugs.
